Phase III efficacy trials of tuberculosis drugs

1) Phase III efficacy trials of new tuberculosis drugs (e.g., bedaquiline, delamanid, PA-824) that have shown promise in early phase studies for multidrug-resistant tuberculosis.

2) Phase III efficacy trials of new and existing tuberculosis drugs to development very short course regimens (3-4 months).

3) Phase III efficacy trials of new and existing drugs for treatment of latent tuberculosis infection in contacts of persons with multidrug-resistant tuberculosis.